Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Brooks

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|February 22, 2005
Tat peptide-mediated cellular delivery: back to basicsHilary Brooks, Bernard Lebleu, Eric Vivès
The Journal of Biological Chemistry|February 3, 2005
Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptorsJean Philippe Richard, Kamran Melikov, Hilary Brooks, et al.
Thrombosis and Haemostasis|May 6, 2006
Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNAAnneke Hecke, Hilary Brooks, Matthieu Meryet-Figuière, et al.
Bioorganic & Medicinal Chemistry|January 9, 2014
Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)Darby G Brooke, Ellen M van Dam, Colin K W Watts, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|February 22, 2005
Tat peptide-mediated cellular delivery: back to basicsHilary Brooks, Bernard Lebleu, Eric Vivès
The Journal of Biological Chemistry|February 3, 2005
Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptorsJean Philippe Richard, Kamran Melikov, Hilary Brooks, et al.
Thrombosis and Haemostasis|May 6, 2006
Successful silencing of plasminogen activator inhibitor-1 in human vascular endothelial cells using small interfering RNAAnneke Hecke, Hilary Brooks, Matthieu Meryet-Figuière, et al.
Bioorganic & Medicinal Chemistry|January 9, 2014
Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3)Darby G Brooke, Ellen M van Dam, Colin K W Watts, et al.
Pageof 1